EPIGALOCATECHIN GALLATE

SynDRA canonical compound SYN0002307 — structure-anchored drug synonym record

Clinical phase	Phase 2/Phase 3
Primary target(s)	APP \| CYP19A1 \| DYRK1A \| ELANE \| ENOX2 \| EP300 \| FASN \| IDO1 \| KAT2B \| KDR \| MMP14 \| MMP2 \| PREP \| SLC5A1
Mechanism of action	bacterial DNA gyrase inhibitor

All known targets

(-)-epigallocatechin gallate
Epigallocatechin gallate
(-)-Epigallocatechin gallate
EGCG
Epigallocatechin-3-gallate
Tea catechin
(-)-Epigallocatechin-3-o-gallate
Teavigo
Epigallocatechin-3-monogallate
(-)-Epigallocatechol gallate
(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate
Catechin deriv
UNII-BQM438CTEL
Green tea extract
CCRIS 3729
(-)-epigallocatechin 3-gallate
C22H18O11
BQM438CTEL
(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl
EGCG analogs
EGCG, Anagen
Epigallocatechin gallate analogs, Anagen
Epigallocatechin gallate, Anagen
GTPs,Anagen
Green tea polyphenols, Anagen
BRD-K55591206
epigallocatechin-gallate-(-)
Epigallocatechin Gallate
Epigallocatechin 3-gallate
(-)-epigallocatechin 3-O-gallate
L-Epigallocatechin gallate
PF-EGCg 90
Epigallocatechingallate
NVP-XAA 723
EPIGALLOCATECHIN 3-O-GALLATE
DTXCID80567
CHEBI:4806
3-O-Galloyl-(-)-epigallocatechin